Article Versions Notes

Trillo Aliaga P, Spitaleri G, Attili I, Corvaja C, Battaiotto E, Angelopoulos PA, Del Signore E, Passaro A, de Marinis F. HER2 in Non-Small Cell Lung Cancer (NSCLC): Evolution of the Therapeutic Landscape and Emerging Drugs—A Long Way to the Top. Molecules. 2025; 30(12):2645. https://doi.org/10.3390/molecules30122645

Trillo Aliaga, Pamela, Gianluca Spitaleri, Ilaria Attili, Carla Corvaja, Elena Battaiotto, Panagiotis Agisilaos Angelopoulos, Ester Del Signore, Antonio Passaro, and Filippo de Marinis. 2025. "HER2 in Non-Small Cell Lung Cancer (NSCLC): Evolution of the Therapeutic Landscape and Emerging Drugs—A Long Way to the Top" Molecules 30, no. 12: 2645. https://doi.org/10.3390/molecules30122645

Trillo Aliaga, P., Spitaleri, G., Attili, I., Corvaja, C., Battaiotto, E., Angelopoulos, P. A., Del Signore, E., Passaro, A., & de Marinis, F. (2025). HER2 in Non-Small Cell Lung Cancer (NSCLC): Evolution of the Therapeutic Landscape and Emerging Drugs—A Long Way to the Top. Molecules, 30(12), 2645. https://doi.org/10.3390/molecules30122645